Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer

被引：0

作者：

Y Kinoshita

K Kuratsukuri

N Newman

P M Rovito

P T P Kaumaya

C Y Wang

G P Haas

机构：

[1] SUNY Upstate Medical University,Department of Urology

[2] SUNY Upstate Medical University,Department of Medicine

[3] Ohio State University,Department of Obstetrics and Gynecology

[4] VA Medical Center,undefined

来源：

Prostate Cancer and Prostatic Diseases | 2005年 / 8卷

关键词：

antibody; prostate-specific membrane antigen; LNCaP; prostate cancer; antitumor activity; glutamate carboxypeptidase II;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Prostate-specific membrane antigen (PSMA) is a target for immunotherapy of prostate cancer. It has been shown that antibodies against PSMA inhibited the in vivo growth of LNCaP tumor. In the present study, monoclonal antibodies against four epitopes in PSMA were raised. MAb 24.4E6 (IgG1), specific for the epitope (residues 638–657) in PSMA, significantly reduced the growth rate of established LNCaP tumor in SCID mice. Mouse IgG was detected in the tumor of mice treated with 24.4E6, but not with an unrelated MAb. These results suggest that this epitope may be the main target in PSMA for antibody therapy of prostate cancer.

引用

页码：359 / 363

页数：4

共 50 条

[21] Prostate-specific membrane antigen as a target for cancer imaging and therapy
Kiess, A. P.
Banerjee, S. R.
Mease, R. C.
Rowe, S. P.
Rao, A.
Foss, C. A.
Chen, Y.
Yang, X.
Cho, S. Y.
Nimmagadda, S.
Pomper, M. G.
[J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (03): : 241 - 268
[22] Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
Watanabe, Rira
Hanaoka, Hirofumi
Sato, Kazuhide
Nagaya, Tadanobu
Harada, Toshiko
Mitsunaga, Makoto
Kim, Insook
Paik, Chang H.
Wu, Anna M.
Choyke, Peter L.
Kobayashi, Hisataka
[J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 140 - 144
[23] Re: Antibody-drug Conjugates Targeting Prostate-specific Membrane Antigen
Montironi, Rodolfo
Lopez-Beltran, Antonio
Cheng, Liang
Scarpelli, Marina
Mazzucchelli, Roberta
Montorsi, Francesco
[J]. EUROPEAN UROLOGY, 2014, 66 (06) : 1190 - 1193
[24] Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
Olson, William C.
Heston, Warren D. W.
Rajasekaran, Ayyappan K.
[J]. REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (03) : 182 - 190
[25] Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane Antigen
Waibel, Sarah
Graf, Nele
Storz, Jonas
Schultze-Seemann, Susanne
Lauw, Susan
Gratzke, Christian
Brueckner, Reinhard
Wolf, Philipp
Wolf, Isis
[J]. ANTICANCER RESEARCH, 2024, 44 (06) : 2343 - 2348
[26] Re: Prostate-Specific Membrane Antigen PET in Prostate Cancer
Siegel, Cary
[J]. JOURNAL OF UROLOGY, 2021, 206 (04): : 1044 - 1044
[27] Advances in prostate-specific membrane antigen PET of prostate cancer
Bouchelouche, Kirsten
Choyke, Peter L.
[J]. CURRENT OPINION IN ONCOLOGY, 2018, 30 (03) : 189 - 196
[28] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
Feneley, MR
Jan, H
Granowska, M
Mather, SJ
Ellison, D
Glass, J
Coptcoat, M
Kirby, RS
Ogden, C
Oliver, RTD
Badenoch, DF
Chinegwundoh, FI
Nargund, VH
Paris, AMI
Britton, KE
[J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) : 47 - 52
[29] Prostate-specific membrane antigen in prostate cancer imaging and treatment
Lim, Emerson
[J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S676 - S689
[30] Updates of prostate cancer staging: Prostate-specific membrane antigen
Sathianathen, Niranjan J.
Lamb, Alastair
Nair, Rajesh
Geurts, Nicolas
Mitchell, Catherine
Lawrentschuk, Nathan L.
Moon, Daniel A.
Murphy, Declan G.
[J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2016, 57 : S147 - S154

← 1 2 3 4 5 →